Life sciences and biotech One Week Remaining: The 2026 storage survey Scientific Computing World and Seagate are inviting research computing professionals to share how they're preparing storage infrastructure for the demands of AI and data-intensive science. Contribute to the 2026 Storage Survey and help benchmark the future of research data management. Latest Content Transforming life sciences research with semantic knowledge technology Bioptimus partners with Cancer Research Horizons to advance AI-powered precision medicine bit.bio announces CRISPR screening service and appoints Chief Technology Officer New technologies Solution Accelerators for biotech research Merz consolidates its R&D with a Life Sciences platform White papers The path to AI federated learning for drug discovery Whether you're working in pharmaceutical R&D, biotechnology, AI development or scientific data management, this White Paper offers valuable perspectives on where federated learning is today Centralising analytical data from mass spectrometry in drug discovery and development Discover how experts from Zoetis, Bayer, LifeMine Therapeutics, Iterion, Targenomix, and the Pistoia Alliance are solving key data challenges for mass spectrometry applications. Standardization of Analytical Data: Best Practices Standardization is critical to extracting the full potential of data. This White Paper offers a comprehensive guide to overcoming challenges and driving progress in analytical chemistry and beyond. Webcasts On Demand Webinar: Consolidating computing resources can democratise research infrastructure More content Case study: Via Nova Therapeutics uses CDD Vault to support global collaboration Advancing bioscience research with machine learning Understanding infection with machine learning 2023 State of Tech in Biopharma report reveals tech strategies in era of data and AI Ganymede Bio and Kytopen to bring cloud-native structured data to gene-modified cell therapy Collaboration aims to facilitate regenerative cell therapy product development Uncovering the mechanisms underlying lack of response to immunotherapy Boosting biotech valuations with cost-efficient addition of key in silico evidence UK government invests £5.5 million in life sciences Acquistion expands Optibrium's 3D drug design and visualisation software Tech Focus: Healthcare software In silico discovery and overcoming bias with AI Pagination Previous page ‹ Previous Page 16 Next page Next ›
